Millennium Management
MRNA icon

Millennium Management’s Moderna MRNA Stock Holding History

Millennium Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.91M Sell
155,800
-232,700
-60% -$10.9M ﹤0.01% 2416
2025
Q4 		$11.5M Sell
388,500
-178,600
-31% -$4.85M ﹤0.01% 2118
2025
Q3 		$14.6M Buy
567,100
+75,200
+15% +$2.1M 0.01% 2009
2025
Q2 		$13.6M Buy
491,900
+183,200
+59% +$4.82M 0.01% 1953
2025
Q1 		$8.75M Buy
308,700
+1,900
+0.6% +$67.4K ﹤0.01% 2324
2024
Q4 		$12.8M Sell
306,800
-112,600
-27% -$5.38M 0.01% 1943
2024
Q3 		$28M Sell
419,400
-183,800
-30% -$16.9M 0.01% 1251
2024
Q2 		$71.6M Buy
603,200
+531,200
+738% +$67.2M 0.03% 583
2024
Q1 		$7.67M Buy
72,000
+4,500
+7% +$454K ﹤0.01% 2434
2023
Q4 		$6.71M Sell
67,500
-107,400
-61% -$9.03M ﹤0.01% 2533
2023
Q3 		$18.1M Buy
174,900
+2,400
+1% +$268K 0.01% 1514
2023
Q2 		$21M Buy
172,500
+16,000
+10% +$2.13M 0.01% 1345
2023
Q1 		$24M Sell
156,500
-253,100
-62% -$41.8M 0.01% 1205
2022
Q4 		$73.6M Sell
409,600
-40,800
-9% -$6.67M 0.04% 534
2022
Q3 		$53.3M Sell
450,400
-213,700
-32% -$32.4M 0.03% 649
2022
Q2 		$94.9M Sell
664,100
-5,500
-0.8% -$786K 0.06% 323
2022
Q1 		$115M Sell
669,600
-52,200
-7% -$8.79M 0.06% 284
2021
Q4 		$183M Buy
721,800
+475,200
+193% +$139M 0.09% 174
2021
Q3 		$94.9M Buy
246,600
+76,600
+45% +$28.3M 0.06% 324
2021
Q2 		$39.9M Buy
170,000
+105,000
+162% +$18.8M 0.02% 723
2021
Q1 		$8.51M Buy
+65,000
New +$9.42M 0.01% 1967
2020
Q4 		– Sell
-4,000
Closed -$283 – 5450
2020
Q3 		$283 Buy
+4,000
New +$279K ﹤0.01% 3877

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's MRNA Position: Q1 2026 in Review

Millennium Management increased its Moderna (MRNA) stake by 153% in Q1 2026, buying an estimated $28.7M and bringing the position to 1,019,208 shares worth $51.8M. The position accounts for 0.02% of the portfolio, ranked #806.

Millennium Management first reported a position in MRNA in Q4 2018 and has held it in 28 quarters since. The position peaked at $98.4M in Q2 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Millennium Management held 1,019,208 shares of Moderna worth $51.8M as of Q1 2026.
  • Millennium Management bought 615,573 Moderna shares in Q1 2026, an estimated $28.7M.
  • Moderna made up 0.02% of Millennium Management's portfolio in Q1 2026, its #806 holding.
  • Millennium Management first reported a position in Moderna in Q4 2018 and has held it in 28 quarters since.
  • Millennium Management's Moderna position peaked at $98.4M in Q2 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.